StrengthMaximal strength
The greatest force a muscle or muscle group can produce in a given movement.
Strength is the greatest force you can produce in a given movement. It is usually measured as a one rep max in a specific lift, which makes it a property of you plus that movement rather than a single universal number.
It comes from two sources. The first is the tissue: how much muscle you have and how it is arranged. The second is the nervous system: how many motor units you can recruit, how fast you can fire them, and how well you coordinate the whole pattern. Early progress is heavily neural, which is why beginners get stronger long before they look different.
Because so much of it is skill, it transfers imperfectly. Getting much stronger at a barbell back squat improves a leg press less than you would expect, and improves a single leg step up less still. Train the thing you want to be strong at.
It matters well beyond the gym. Grip strength, an easy proxy for whole body strength, is associated with all cause mortality and with cardiovascular, respiratory and cancer outcomes in half a million UK Biobank participants, and muscle strength is now the primary diagnostic criterion for sarcopenia ahead of muscle size.
Building it means training heavy enough to demand high force, often described as work above roughly 80% of your maximum, with enough recovery between sets to produce quality efforts rather than fatigue. That is a different session structure from hypertrophy work, though the two overlap heavily in practice.
Progress slows dramatically and permanently. A beginner may add weight weekly for months; an experienced lifter measures a good year in a handful of kilograms. That is not failure, it is the shape of the curve, and expecting otherwise is what leads people to programme hop.
In practice, estimate your maxes with our one rep max calculator, compare them against our strength standards for context, and judge progress across years.
Sources
- Celis-Morales CA, et al. Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants. BMJ 2018;361:k1651
- Cruz-Jentoft AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis (EWGSOP2). Age Ageing 2019;48:16-31